摘要:
A novel structural class of p38 alpha MAP kinase inhibitors has been identified via iterative SAR studies of a focused deck screen hit. Optimization of the lead series generated 6e, BMS-640994, a potent and selective p38 alpha inhibitor that is orally efficacious in rodent models of acute and chronic inflammation. (C) 2008 Elsevier Ltd. All rights reserved.